International journal of colorectal disease
-
Int J Colorectal Dis · Jul 2003
Clinical TrialA pilot study of irinotecan (CPT-11) as single-agent therapy in patients with locally advanced or metastatic esophageal carcinoma.
This study assessed the efficacy and safety of irinotecan (CPT-11) in the treatment of patients with unresectable esophageal carcinoma. ⋯ CPT-11 as single-agent therapy is modestly effective against squamous cell cancer of the esophagus.